Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / The objective of this work was to evaluate the effects of HgCl2 exposure in drinking water in pregnant and/or lactating rats and their offspring. Still, it evaluated if the HgCl2 intravenous exposure as well as the renal damage induced by this exposure altered the offspring mercury content. The drinking water (v.o.) HgCl2 exposure protocol was as follows: Female Wistar rats were exposed to HgCl2 (0, 0.2, 0.5, 10 and 50 μg Hg2+/mL) from gestation day 0 until 20 or until the last day of lactation. Every two days, the mercury solutions were changed, food and water intake and rats weight were analyzed. The offspring was killed on gestation day 20 and on the post-natal days 10, 20, 30 and 40. Tissues weight, essential metal homeostasis, mercury content and biochemical parameters were evaluated. Behavioral tasks were carried out on post-natal days 3, 5, 7, 9 and 11 (negative geotaxis test) and 17, 18, 19 and 20 (beaker test). The intravenous (i.v.) HgCl2 exposure protocol was as follows: Female Wistar rats were exposed to HgCl2 (0.5 and 2.5 μmol HgCl2/kg/2 mL) on gestation day 20 and killed 6 h later or on gestation day 18 and killed 48 h later. Hg maternal and fetal distribution and renal damage through histology and biochemical and molecular markers were evaluated. Dams exposed to HgCl2 v.o. presented water intake decreased. The exposure to 50 μg Hg2+/mL caused an increase in relative renal weight. Animals exposed to 10 and 50 μg Hg2+/mL presented an increase in renal and hepatic Cu and Zn levels, respectively, and mercury accumulation (pregnant rats); and, an increase in total thiol and metallothionein renal levels (lactating rats). The offspring only presented an increase in hepatic porfobilinogensynthase activity (fetuses) and in relative renal weight (post-natal day 20). The pregnant rats exposed i.v. to HgCl2 presented the greater mercury accumulation in kidney in both periods analyzed; although 48 h after the exposure the Hg levels were lower than at 6 h. The exposure to 2.5 μmol HgCl2/kg/2 mL caused an increase in serum creatinine levels and in Kim-1 renal expression as well as renal histology alterations. The placental and fetal Hg did not change in both periods analyzed; the increase in fetal organs Hg levels were dose and time dependent. In conclusion, the exposure to low doses of HgCl2 in drinking water caused mild alterations in dams; also the dam organism was able to handle the Hg avoiding offspring damages; probably, this protection is related with the increase on scavenger molecules (metallothionein, for example) during the pregnancy and lactation. Besides, we verified that when dams were exposed intravenously to HgCl2, the developing organisms (fetuses) were unable to excrete/depurate the Hg. / O objetivo deste trabalho foi avaliar os efeitos da exposição ao HgCl2 na água de beber em ratas prenhas e/ou lactantes e sua prole. Ainda, avaliar se a exposição intravenosa ao HgCl2 assim como o dano renal induzido pela mesma altera a deposição de mercúrio na prole. O protocolo de exposição ao HgCl2 na água de beber (v.o.) foi: as ratas Wistar foram expostas ao HgCl2 (0, 0,2, 0,5, 10 e 50 μg Hg2+/mL) do dia zero de gestação até o dia 20 ou até o final da lactação. A cada dois dias, as soluções de mercúrio eram trocadas, a ingestão de comida e água e o peso das ratas eram avaliados. A prole foi sacrificada no dia 20 de gestação e nos dias pós-natal 10, 20, 30 e 40. Foram analisados o peso dos órgãos, a homeostase de metais essenciais, os níveis de mercúrio e parâmetros bioquímicos. As tarefas comportamentais foram realizadas nos dias pós-natal 3, 5, 7, 9 e 11 (teste do geotactismo negativo) e 17, 18, 19 e 20 (teste do beaker). O protocolo de exposição ao HgCl2 intravenoso (i.v.) foi: as ratas Wistar foram expostas ao HgCl2 (0,5 e 2,5 μmol HgCl2/kg/2 mL) no dia 20 de gestação e sacrificadas 6 h após a exposição ou no dia 18 de gestação e sacrificadas 48 h após a exposição. Foram avaliados a distribuição do Hg nos organismos materno e fetal e o dano renal através de histologia e marcadores bioquímicos e moleculares. As mães expostas ao HgCl2 v.o. apresentaram diminuição na ingestão de água; a exposição a dose de 50 μg Hg2+/mL causou aumento no peso relativo de rim. As doses de 10 e 50 μg Hg2+/mL causaram aumento dos níveis renais de Cu e hepáticos de Zn e acúmulo de mercúrio em rins nas gestantes; e aumento nos níveis renais de tióis totais e de metalotioneínas nas lactantes. A prole exposta ao HgCl2 apresentou aumento da atividade hepática da porfobilinogênio sintase em fetos e aumento do peso relativo de rim no dia pós-natal 20. As ratas expostas ao HgCl2 i.v. apresentaram maior acúmulo de mercúrio em rins 6 e 48 h após a exposição; embora a 48 h da exposição, os níveis já haviam diminuído em relação a 6 h. A dose de 2,5 μmol HgCl2/kg/2 mL i.v. causou aumento nos níveis séricos de creatinina, aumento da expressão da proteína Kim-1 e alterações na histologia de rim. Os níveis de Hg placentário e fetal não diminuíram com o passar das horas após a exposição; nos órgãos fetais, os níveis de Hg apresentaram aumento dependente da dose e do tempo. Em conclusão, a exposição a baixas doses de HgCl2 na água de beber causou alterações brandas nas mães; e o organismo materno parece ter metabolizado o Hg, evitando danos à prole; provavelmente esta proteção está relacionada ao aumento dos níveis de moléculas detoxificantes (metalotioneínas, por exemplo) durante o período gestacional e lactacional. Ainda, verificamos a incapacidade dos organismos em desenvolvimento (fetos) em excretar/depurar os íons Hg quando as mães foram expostas intravenosamente ao metal.

L'utilisation des nanobiotechnologies dans le domaine de la santé est en plein essor. Les nanoparticules de poly(acide lactique) (PLA) représentent un nanosystème biocompatible capable d'accroître la spécificité et l'efficacité de traitements thérapeutiques et vaccinaux administrables par voie muqueuse et intraveineuse. Toutefois, l'optimisation de ces nanosystèmes se heurte à une caractérisation incomplète de leur biodistribution in vivo, en particulier à l'échelle cellulaire.L'objectif de ce travail de thèse est d'enrichir les connaissances sur la biodistribution des nanoparticules de PLA in vivo après administration muqueuse ou intraveineuse, dans le but d'élargir les perspectives d'optimisation et d'utilisation. Animal complexe et adapté pour les études sur organisme-entier, le modèle du poisson-zèbre (Danio rerio) a été utilisé. Pour mener à bien ce projet, une méthodologie rigoureuse d'analyse de la biodistribution des nanoparticules de PLA a été développée. Ce qui permit, après administration par balnéation, d'en révéler le fort tropisme inné envers les cellules dendritiques muqueuses. Ces données ont servi à élaborer une stratégie de ciblage, utilisant la lectine agglutinine de cacahuète, capable d'augmenter la prise en charge des nanoparticules de PLA par les branchies et la peau. Enfin, l'étude du devenir de ces nanoparticules après injection intraveineuse, a révélé de nombreuses interactions avec le système circulatoire. Ce travail a permis d'approfondir la connaissance des interactions des nanoparticules de PLA avec le vivant, soulignant le potentiel prometteur de ces nanoparticules pour la vaccination muqueuse / Medecine shows a growing interest regarding nanobiotechnologies. Among them are poly(lactic acid) (PLA) nanoparticles, which represent a biocompatible and competent nanosystem to heighten the specificity and efficacy of diverse therapeutic and vaccine treatments, following mucosal and intravenous administration. However, the further optimization of such nanosystem is poised by the lack of informations regarding their in vivo biodistribution, especially at the cellular level.The main objective of this PhD is to increment the knowledge about PLA nanoparticles biodistribution in vivo, after muquous and intravenous administration, to further expand their optimisation and use perspectives. The zebrafish model has been utilized to perform this research because of his conserved complexity as well as his suitability for whole-organism studies.To fulfill this project, a precise methodology has been developed to analyze the PLA nanoparticles biodistribution. Which allowed, after bathing administriation, to unveil their robust innate tropism toward mucous dendritic cells. From these data has been established a targeting strategy, utilizing the peanut agglutinin lectin, which has been proved to enhance nanoparticle uptakes by both gills and skin mucosae. Finally, the study of PLA nanoparticles behavior and destiny after intravenous injection, revealed numerous elaborated interactions with the circulatory system.Overall, this work has been able to strengthen our understandings of PLA nanoparticles among living organisms, furthermore highlighting their promizing potential as nanovehicles for mucosal vaccines

No description available.

Background: Surgical procedures are invariably accompanied by the use of inhalational and intravenous anesthetics. Both groups have strong influence on cardiovascular system by the interaction with myocardial oxygen supply/demand ratio and cardiomyocyte functions at the level of cell membranes, ion channels and regulatory enzymes. Aims: 1. To examine the effects of different isoflurane concentrations on the left ventricular (LV) dimensions and systolic function in the rat. 2. To examine the effects of isoflurane-induced myocardial preconditioning (APC) on the cardiac tolerance to ischemia- reperfusion (I-R) injury. 3. To compare the influence of anesthesia, based on ketamine- dexmedetomidine (KET-DEX), on the release of biochemical markers of myocardial injury and the early postoperative course with the anesthesia, based on sevoflurane-sufentanil (SEVO), in the patients undergoing coronary artery bypass grafting (CABG). Methods: 1. We carried out transthoracic echocardiographic examination in the rats immobilized by 1.5-3% concentration of isoflurane. 2. After inducing APC by isoflurane (0.5 and 1 MAC), we evaluated ventricular arrhythmias during regional ischemia (45 min), induced by the occlusion of the left anterior descending artery, and subsequent reperfusion (60 min), using the model of...

Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.

Background: Surgical procedures are invariably accompanied by the use of inhalational and intravenous anesthetics. Both groups have strong influence on cardiovascular system by the interaction with myocardial oxygen supply/demand ratio and cardiomyocyte functions at the level of cell membranes, ion channels and regulatory enzymes. Aims: 1. To examine the effects of different isoflurane concentrations on the left ventricular (LV) dimensions and systolic function in the rat. 2. To examine the effects of isoflurane-induced myocardial preconditioning (APC) on the cardiac tolerance to ischemia- reperfusion (I-R) injury. 3. To compare the influence of anesthesia, based on ketamine- dexmedetomidine (KET-DEX), on the release of biochemical markers of myocardial injury and the early postoperative course with the anesthesia, based on sevoflurane-sufentanil (SEVO), in the patients undergoing coronary artery bypass grafting (CABG). Methods: 1. We carried out transthoracic echocardiographic examination in the rats immobilized by 1.5-3% concentration of isoflurane. 2. After inducing APC by isoflurane (0.5 and 1 MAC), we evaluated ventricular arrhythmias during regional ischemia (45 min), induced by the occlusion of the left anterior descending artery, and subsequent reperfusion (60 min), using the model of...

No description available.

No description available.

The efficacy and safety of oral nadolol in supraventricular tachycardia were evaluated prospectively in 27 children (median age 5.5 years). Fifteen patients had an unsuccessful trial of digoxin therapy. Intravenous nadolol was given to seven patients during electrophysiologic study; five of these had an excellent response and two had a partial response (25% decrease in tachycardia rate). Six of these patients had a similar response to oral nadolol. Twelve patients received both propranolol and nadolol. Among six patients, intravenous propranolol was successful in four and unsuccessful in two; all six had a similar response to oral nadolol. With oral propranolol, tachycardia was well controlled in four patients and persistent in two; five of five patients had a similar response to oral nadolol. Twenty-six patients were treated with oral nadolol; the arrhythmia was well controlled in 23, 2 had recurrent tachycardia and 1 patient had tachycardia at a 25% slower rate. The effective dose of nadolol ranged between 0.5 and 2.5 mg/kg body weight once daily (median dose 1 mg/kg per day). During follow-up (3 to 36 months), compliance and tolerance were excellent; excluding 2 patients with reactive airway disease who developed wheezing, only 3 (12%) of 24 had side effects necessitating a change in drug therapy. Once a day nadolol is a safe and effective agent in the management of supraventricular tachycardia in children. Its long-term efficacy can be predicted by the short-term response to intravenous nadolol or propranolol during programmed electrophysiologic study.

The purpose of the study was to explore the experiences of female nyaope injectors residing in City of Tshwane Municipality, Gauteng. The study was conducted at COSUP sites namely; Soshanguve, Pretoria CBD, Sunnyside, Mamelodi, Eersterust, and Attridgeville. The study focused on females who have a history of injecting nyaope, accessing substance use related services at a registered service provider within City of Tshwane Municipality, Gauteng. Research design of the study was exploratory, which is basically used to explore a new topic or learn more about phenomenon where little is known. The research approach was purely qualitative methodology. This permitted the researcher to deeply explore the lived experiences of female nyaope injectors residing in City of Tshwane Municipality, Gauteng. A qualitative in-depth interview method was used to collect data from 24 participants who took part in the study. Questions of the interview were semi-structured, in-depth one-on-one interviews and were used to explore the lived experiences of female nyaope injectors residing in City of Tshwane Municipality, Gauteng. The findings of the study revealed that females who are injecting nyaope, are at risk of contracting HIV and other blood-borne infections. The stigma that is perpetuated by families, intimate partners, communities, health care professionals, and police officers is creating a hostile environment for female nyaope injectors; which increases the risk of contracting HIV and other blood-borne infections. Harm reduction services have the potential to address the needs of female nyaope injectors if fully implemented. It can be concluded that there is a need for substance abuse service providers to implement comprehensive harm reduction services to curb HIV prevalence amongst female nyaope injectors. / Health Studies / M.A. (Social Behavioural Studies in HIV/AIDS)